<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04489654</url>
  </required_header>
  <id_info>
    <org_study_id>interventional</org_study_id>
    <nct_id>NCT04489654</nct_id>
  </id_info>
  <brief_title>Immediate Implant Using Socket Shield Technique With Xenogenic Bone Graft</brief_title>
  <official_title>Evaluation of Immediate Implant Placement With a Modified Socket Shield Technique Using Xenogenic Bone Graft. (a Randomized Controlled Clinical Trial) CLINICAL TRIAL)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alexandria University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alexandria University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adequate bone volume and a proper aesthetic outcome have become the main focus of interest in&#xD;
      implant dentistry. Alveolar bone resorption is a natural course occurring after tooth&#xD;
      removal. Partial extraction therapy through root preservation has been reported to help in&#xD;
      bone maintenance at the extraction site. In 2010, Hurzeler et al. evaluated a new approach,&#xD;
      at that time, called socket shield technique. Han et al. in 2018 reported the modification of&#xD;
      this technique and leaving the jump gap between the shield and the implant non-grafted. The&#xD;
      importance of bone grafting of the gap between the implant and the labial shield in improving&#xD;
      quality of regenerating bone and prevention of the soft tissue ingrowth has been described.&#xD;
      Thus the hypothesis, of improving the modified socket shield technique by bone grafting could&#xD;
      be tested.&#xD;
&#xD;
      Aim of this study is to evaluate the clinical and radiographic outcomes of using xenogenic&#xD;
      bone graft on outcome of immediate dental implant placement using the modified socket shield&#xD;
      technique.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      16 patients who are admitted to the outpatient clinic of Oral and Maxillofacial Surgery&#xD;
      Department, are divided into two study groups. Control group will receive an immediate&#xD;
      implant with modified socket shield technique. Test group will receive immediate implant with&#xD;
      modified socket shield and deproteinized bovine bone mineral (DBBM) put in the buccal gap.&#xD;
      Outcome measurement is primary and secondary implant stability measurement and CBCT&#xD;
      evaluation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">July 20, 2019</start_date>
  <completion_date type="Anticipated">October 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 14, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>primary and secondary implant stability measurement</measure>
    <time_frame>4 months</time_frame>
    <description>Implant stability measured in units ISQ is concluded through a clinical evaluation using ostell</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bone mineral density</measure>
    <time_frame>6 months</time_frame>
    <description>Bone mineral density is calculated through radiographic evaluation by means of cone beam CT</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Immediate Implant</condition>
  <arm_group>
    <arm_group_label>study</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Test group will receive immediate implant with modified socket shield and deproteinized bovine bone mineral (DBBM) OneXeno Graft. ( OneGraft, Germany) put in the buccal gap</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group will receive an immediate implant with modified socket shield technique but without deproteinized bovine bone mineral (DBBM) OneXeno Graft. ( OneGraft, Germany) in the buccal gap</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>deproteinized bovine bone mineral (DBBM) by OneXeno Graft. ( OneGraft, Germany)</intervention_name>
    <description>deproteinized bovine bone mineral (DBBM) put in the gap between implant and labial shield</description>
    <arm_group_label>study</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age more than 18 years old irrespective of the gender&#xD;
&#xD;
          -  One or more of non-restorable (fractured or decayed) tooth/teeth in the upper&#xD;
             aesthetic regions (incisors, premolars).&#xD;
&#xD;
          -  Free from periodontal diseases.&#xD;
&#xD;
          -  Sufficient bone volume to allow placement of an implant.&#xD;
&#xD;
          -  Ability to read and sign an informed consent form&#xD;
&#xD;
          -  Adequate buccolingual width to allow for a buccal gap presence.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  A medical history that contraindicates oral surgical treatment (uncontrolled/untreated&#xD;
             diabetes mellitus, immuno-compromised status, radio/chemotherapy of the oral and&#xD;
             maxillofacial region, treatment with oral and/or intravenous amino-bisphosphonates).&#xD;
&#xD;
          -  Untreated periodontal disease.&#xD;
&#xD;
          -  Vertical root fractures on the buccal aspect.&#xD;
&#xD;
          -  Tooth /teeth with horizontal fractures below bone level.&#xD;
&#xD;
          -  Tooth /teeth with external or internal resorptions.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>lubna f elsharkawy, BDS</last_name>
    <phone>01200508371</phone>
    <email>lubna_elsharkawy@Hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Alexandra university</name>
      <address>
        <city>Alexandria</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 19, 2020</study_first_submitted>
  <study_first_submitted_qc>July 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 28, 2020</study_first_posted>
  <last_update_submitted>July 25, 2020</last_update_submitted>
  <last_update_submitted_qc>July 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

